Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00169455
Status:
COMPLETED
Last Update Posted:
2017-01-16
First Post:
2005-09-09
Brief Title:
Assess the Immunogenicity of the Human Rotavirus HRV Vaccine After Reconstitution Without Buffering Agent Evaluate the Immunogenicity Reactogenicity Safety of the Vaccine After Storage for 7 d at 37C Following 2 Doses in Healthy Infants
Sponsor:
Organization:
GlaxoSmithKline
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
450
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: